Literature DB >> 9755840

Human colon cancer cells express the functional Fas ligand.

E X Ding1, A Hizuta, Y Morimoto, T Tanida, T Hongo, T Ishii, T Yamano, T Fujiwara, H Iwagaki, N Tanaka.   

Abstract

Fas ligand (FasL) belongs to the TNF superfamily. It is induced in activated lymphocytes and eliminates Fas-positive lymphocytes, resulting in the down-regulation of immune responses. FasL has also been detected in tissues other than lymphoid cells. We investigated the expression and function of FasL on human colon cancer cells. FasL mRNA was detected by RT-PCR in all six colon cancer cell lines tested and was not found on fibroblasts. FasL protein was detected in DLD-1, LoVo, HCT-116 and RPMI 4788 cells by immunohistochemical staining. DLD-1, LoVo and WiDr were cytotoxic against mouse T lymphoma cells which were transfected with human Fas receptor cDNA. The cytotoxicity was significantly enhanced by phorbol 12-myristate 13-acetate (PMA) and ionomycin. Our data suggest that the FasL expressed in human colon cancer cells may be regulated by endogenous factors in the microenvironment of the host and facilitates the escape from the host immune system.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9755840

Source DB:  PubMed          Journal:  Res Commun Mol Pathol Pharmacol        ISSN: 1078-0297


  4 in total

1.  Relationship between Fas/FasL expression and apoptosis of colon adenocarcinoma cell lines.

Authors:  Z H Peng; T H Xing; G Q Qiu; H M Tang
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

2.  Cytoplasmic overexpression of CD95L in esophageal adenocarcinoma cells overcomes resistance to CD95-mediated apoptosis.

Authors:  Gregory A Watson; Sanjay Naran; Xinglu Zhang; Michael T Stang; Pierre E Queiroz de Oliveira; Steven J Hughes
Journal:  Neoplasia       Date:  2011-03       Impact factor: 5.715

3.  Bladder cancer cells acquire competent mechanisms to escape Fas-mediated apoptosis and immune surveillance in the course of malignant transformation.

Authors:  F G Perabo; S Kamp; D Schmidt; H Lindner; G Steiner; R H Mattes; A Wirger; K Pegelow; P Albers; E C Kohn; A von Ruecker; S C Mueller
Journal:  Br J Cancer       Date:  2001-05-18       Impact factor: 7.640

4.  Expression of FAP-1 by human colon adenocarcinoma: implication for resistance against Fas-mediated apoptosis in cancer.

Authors:  H Yao; E Song; J Chen; P Hamar
Journal:  Br J Cancer       Date:  2004-11-01       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.